ClinicalTrials.Veeva

Menu

Targeting the Skeletal Muscle to Treat Metabolic Dysfunction-associated Steatotic Liver Disease (MYO-MASLD)

C

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Status

Not yet enrolling

Conditions

Metabolic Dysfunction-associated Steatotic Liver Disease

Treatments

Other: Moderate intensity exercise training
Other: Low intensity exercise training
Other: High-intensity interval training

Study type

Interventional

Funder types

Other

Identifiers

NCT06506513
ST-IR-01 MYO-MASLD

Details and patient eligibility

About

Muscle changes including myosteatosis are reported as highly prevalent in metabolic dysfunction-associated steatotic liver disease (MASLD). Recent studies highlighted a link between muscle fat content and liver disease severity. Conversely, MASLD histological remission though diet or metabolic surgeries is also linked to a decrease in muscle fat content. Therefore, skeletal muscle appears as a potential target to treat MASLD.

Full description

In this monocenter interventional study, we will assess the impact of physical activity on muscle fat content and liver disease severity in MASLD as well as the mechanisms mediating the potential beneficial effects of exercise.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • confirmed MASLD at abdominal imaging
  • confirmed excessive muscle lipid content at imaging
  • stable weight

Exclusion criteria

  • severe comorbidities including active malignancies, neuromuscular degenerative diseases
  • contraindications to physical activity
  • excessive alcohol consumption

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 3 patient groups

control group
Active Comparator group
Description:
in this control group, patients will perform non-cardiovascular non-intensity training (stretching, meditation).
Treatment:
Other: Low intensity exercise training
moderate-intensity low interval training group
Active Comparator group
Description:
In this group, patients will perform moderate-intensity low interval training.
Treatment:
Other: Moderate intensity exercise training
high-intensity interval training
Active Comparator group
Description:
In this group, patients willp erform high-intensity interval training.
Treatment:
Other: High-intensity interval training

Trial contacts and locations

2

Loading...

Central trial contact

Nicolas Lanthier, MD, PhD; Guillaume Henin, MD, PhD student

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems